CompletedNot Applicable

Adding Core Stabilization Training to Manuel Therapy in Temporomandibular Joint Disorders

Turkey (Türkiye)45 participantsStarted 2022-11-06

Plain-language summary

This study aims to compare the effectiveness of three different treatment approaches in individuals with DDwR symptoms. It is hypothesized that adding core stabilization training (CST) to orofacial manual therapy (OMT) will enhance treatment outcomes. Patients will be treated for 10 sessions once a week, for a total of 10 weeks. Evaluation was planned to be done twice, at the beginning and end of the treatment.

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Volunteered to participate, * Aged between 18-60 years old, * Having the diagnosis of Temporomandibular Disorders (TMD) - Reduction Disc Displacement (DDwR) Exclusion Criteria: * Having a malignant condition, trauma and surgery of the cranial and cervical region, * Not being cooperative, * Regular use of analgesic and anti-inflammatory drugs, * Having dentofacial anomalies, * Having active arthritis, * Having lumbal pathology, * Having metabolic diseases, * Having connective tissue, rheumatological and hematological disorders, * Having a diagnosed psychiatric illness, * Receiving TMD-related physical therapy less than 6 months ago

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Pain severity: VAS

Timeframe: Change from Baseline pain severity at 10 weeks.

Pain Threshold: Digital algometer

Timeframe: Change from Baseline pain threshold at 10 weeks.

Range of Motion

Timeframe: Change from Baseline range of motion at 10 weeks.

Facial asymmetry

Timeframe: Change from Baseline facial asymmetry at 10 weeks.

Degree of pelvic tilt

Timeframe: Change from Baseline degree of pelvic tilt at 10 weeks.

Degree of lordosis

Timeframe: Change from Baseline degree of lordosis at 10 weeks.

Trial details

NCT IDNCT05607823

SponsorMarmara University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-01

View on ClinicalTrials.gov More Temporomandibular Joint Disorders trials